For research use only. Not for therapeutic Use.
KAT6-IN-1（Cat No.:I041157）is a small molecule inhibitor that selectively targets KAT6 (lysine acetyltransferase 6), an enzyme involved in histone acetylation and gene regulation. KAT6 plays a crucial role in chromatin remodeling, transcriptional activation, and cellular processes such as differentiation and proliferation. By inhibiting KAT6, KAT6-IN-1 modulates gene expression, potentially influencing cancer progression, stem cell biology, and other diseases linked to aberrant epigenetic regulation. This compound is under investigation for its therapeutic potential in oncology and other disorders where dysregulated acetylation contributes to disease development and progression.
| CAS Number | 2569008-99-5 |
| Synonyms | 2-methoxy-N-[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]benzenesulfonamide |
| Molecular Formula | C19H18N4O5S |
| Purity | ≥95% |
| IUPAC Name | 2-methoxy-N-[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]benzenesulfonamide |
| InChI | InChI=1S/C19H18N4O5S/c1-26-14-6-3-4-7-17(14)29(24,25)22-19-18-15(27-2)10-13(11-16(18)28-21-19)12-23-9-5-8-20-23/h3-11H,12H2,1-2H3,(H,21,22) |
| InChIKey | RCBWSTJGOASLEO-UHFFFAOYSA-N |
| SMILES | COC1=CC=CC=C1S(=O)(=O)NC2=NOC3=C2C(=CC(=C3)CN4C=CC=N4)OC |
